About CairnSurgical
CairnSurgical is a company based in Lebanon (United States) founded in 2015. CairnSurgical has raised $7.79 million across 8 funding rounds from investors including NIH, HHS and National Cancer Institute. CairnSurgical offers products and services including Breast Cancer Locator System and Visualizer. CairnSurgical operates in a competitive market with competitors including Augmedics, Proprio, ClearPoint Neuro, IMRIS Deerfield Imaging and eCential Robotics, among others.
- Headquarter Lebanon, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cairnsurgical, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$7.79 M (USD)
in 8 rounds
-
Latest Funding Round
$4.5 M (USD), Series A
Aug 21, 2024
-
Investors
NIH
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of CairnSurgical
CairnSurgical offers a comprehensive portfolio of products and services, including Breast Cancer Locator System and Visualizer.
3D-printed system for precise tumor localization in breast surgery.
Interactive tool for viewing tumor areas during surgical procedures.
People of CairnSurgical
Unlock access to complete
Unlock access to complete
Funding Insights of CairnSurgical
CairnSurgical has successfully raised a total of $7.79M across 8 strategic funding rounds. The most recent funding activity was a Series A round of $4.5 million completed in August 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in CairnSurgical
CairnSurgical has secured backing from 5 investors, including institutional investors. Prominent investors backing the company include NIH, HHS and National Cancer Institute.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked | |
|
Federal innovation and scientific achievement services are provided.
|
Locked | Locked | Locked |
Investor details for CairnSurgical
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CairnSurgical
Investment portfolio details for CairnSurgical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - CairnSurgical
Detailed financials for CairnSurgical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cairnsurgical Comparisons
Peer comparison for CairnSurgical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CairnSurgical
CairnSurgical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Augmedics, Proprio, ClearPoint Neuro, IMRIS Deerfield Imaging and eCential Robotics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Augmented reality systems for guiding surgical procedures are developed.
|
|
| Locked | Locked | Locked |
Visualization systems for surgical procedures are developed using machine learning.
|
|
| Locked | Locked | Locked |
Software and hardware solutions for MRI-guided surgical planning are provided.
|
|
| Locked | Locked | Locked |
Surgical theatres with ceiling mounted mobile imaging devices to enhance intraoperative workflow
|
|
| Locked | Locked | Locked |
Robotic surgery platform for bone procedures is developed.
|
|
| Locked | Locked | Locked |
Platform for breast ultrasound imaging
|
Detailed competitors of CairnSurgical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cairnsurgical
Complete news archive for CairnSurgical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CairnSurgical
CairnSurgical was founded in 2015 and raised its 1st funding round 1 year after it was founded.
CairnSurgical is headquartered in Lebanon, United States.
CairnSurgical is a funded company, having raised a total of $7.79M across 8 funding rounds to date.
CairnSurgical was founded in 2015 and is based in Lebanon, United States. Operations focus on the medical device sector, where 3D-printed surgical guides are developed for breast cancer treatment. The proprietary Breast Cancer Locator System is utilized to map tumor size, shape, and margins, aiding surgeons in precise excision while preserving healthy tissue. This approach is applied during lumpectomy procedures to minimize positive margins.
CairnSurgical's top competitors include Augmedics, Proprio and Delphinus Medical Technologies.
CairnSurgical offers Breast Cancer Locator System and Visualizer.
CairnSurgical has 5 investors. Key investors include NIH, HHS, National Cancer Institute, SBIR, and Morningside Ventures.